When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IMGN - ImmunoGen EPS beats by $0.02 misses on revenue; reaffirms guidance
ImmunoGen Inc.
ImmunoGen (IMGN): Q1 GAAP EPS of -$0.17 beats by $0.02.Revenue of $15.7M (+18.1% Y/Y) misses by $1.82M.For 2021, ImmunoGen guidance remains unchanged: Revenues between $65M and $75M vs. consensus of $70.70M; operating expenses between $200M and $210M; and cash and cash equivalents at December 31, 2021 to be between $140M and $150M.ImmunoGen expects that its current cash will fund operations into the second half of 2022.Shares -1.77% PM.Press Release